Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 050417
Company: CASPER PHARMA LLC
Company: CASPER PHARMA LLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LUMI-SPORYN | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM | OINTMENT;OPHTHALMIC | Prescription | AT | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/10/1971 | ORIG-1 | Approval | UNKNOWN |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
05/21/2020 | SUPPL-12 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050417s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/050417Orig1s012ltr.pdf | |
04/30/2004 | SUPPL-11 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50417slr011_neosporin_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50417slr011ltr.pdf | |
04/19/1999 | SUPPL-10 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/23/1999 | SUPPL-9 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/09/1995 | SUPPL-8 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
09/22/1993 | SUPPL-7 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
03/23/1993 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
08/10/1992 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/10/1994 | SUPPL-4 | Labeling |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
05/21/2020 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050417s012lbl.pdf | |
05/21/2020 | SUPPL-12 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050417s012lbl.pdf | |
04/30/2004 | SUPPL-11 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50417slr011_neosporin_lbl.pdf |
LUMI-SPORYN
OINTMENT;OPHTHALMIC; EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
LUMI-SPORYN | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM | OINTMENT;OPHTHALMIC | Prescription | Yes | AT | 050417 | CASPER PHARMA LLC |